Nox Peptides, a Toronto-based supplier of research compounds, announces new and expanded support for Canadian research organizations, with a focus on BPC-157. The company says it is launching a BPC-157 research product alongside supporting research resources for laboratories, academic researchers, and independent research groups.
Across outlets, the announcement is framed as responding to growing interest and demand for peptide-based research in Canada. One report highlights the company’s expanded research focus and information/access approach for peptide supplies used in preclinical and laboratory work, while another emphasizes the specific product launch and the availability of research materials tied to BPC-157. Both accounts describe the initiative as part of Nox Peptides’ broader research-oriented product offering, presented for scientific users in the Canadian market.
No sources provide additional details such as pricing, regulatory status, distribution scope, or timelines beyond the Oct. 6, 2026 announcement date.
